搜索医生

John E. Eaton, M.D.

  1. Gastroenterologist
  2. Internist
预约门诊

出版物

  1. Mouchli MA, Osman MK, Busebee B, Taner T, Heimbach JK, Eaton J, Mousa O, Cole K, Watt KD. Long term (15 year) complications & outcomes after liver transplantation for primary sclerosing cholangitis: Impact of donor and recipient factors. Liver Transpl. 2024 Oct 28 [Epub ahead of print]
    View PubMed
  2. Aggarwal M, Simadibrata DM, Kipp BR, Prokop LJ, Barr Fritcher EG, Schneider A, Cooley MA, Gores GJ, Eaton J, Roberts LR, Chandrasekhara V. Diagnostic Accuracy Performance of Fluorescence In Situ Hybridization (FISH) for Biliary Strictures: A Systematic Review and Meta-Analysis. J Clin Med. 2024 Oct 28; 13 (21)
    View PubMed
  3. Lam L, Soret PA, Lemoinne S, Hansen B, Hirschfield G, Gulamhusein A, Montano-Loza AJ, Lytvyak E, Pares A, Olivas I, Londono MC, Rodriguez-Tajes S, Eaton JE, Osman KT, Schramm C, Sebode M, Lohse AW, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Floreani A, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Sobenko N, Villamil AM, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Bruns T, Grosse K, Wetten A, Dyson JK, Jones D, Levy C, Tanaka A, Dumortier J, Pageaux GP, de Ledinghen V, Carrat F, Chazouilleres O, Corpechot C, Global & ERN Rare-Liver PBC Study Groups. Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2024 Jul 15 Epub 2024 July 15
    View PubMed
  4. Nasser-Ghodsi N, Eaton JE, Smith BH, Venkatesh SK, Heimbach JK, Taner T, Welle CL, Ilyas SI, Gores GJ, Rosen CB. Transplantation Within 6 Months of Registration does not Enhance Survival for Patients with Perihilar Cholangiocarcinoma. Ann Surg. 2024 Jul 4 Epub 2024 July 04
    View PubMed
  5. Urquhart SA, Comstock BP, Jin MF, Day CN, Eaton JE, Harmsen WS, Raffals LE, Loftus EV Jr, Coelho-Prabhu N. The Incidence of Pouch Neoplasia Following Ileal Pouch-Anal Anastomosis in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2024 Feb 01; 30(2):183-189.
    View PubMed
  6. Corpechot C, Lemoinne S, Soret PA, Hansen B, Hirschfield G, Gulamhusein A, Montano-Loza AJ, Lytvyak E, Pares A, Olivas I, Eaton JE, Osman KT, Schramm C, Sebode M, Lohse AW, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Floreani A, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Sobenko N, Villamil AM, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Bruns T, Grosse K, Wetten A, Dyson JK, Jones D, Dumortier J, Pageaux GP, de Ledinghen V, Chazouilleres O, Carrat F, Global & ERN Rare-Liver PBC Study Groups. Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? Hepatology. 2024 Jan 1; 79 (1):39-48 Epub 2023 July 03
    View PubMed
  7. Singh Y, Faghani S, Eaton JE, Venkatesh SK, Erickson BJ. Deep learning–based prediction of hepatic decompensation in patients with primary sclerosing cholangitis with computed tomography. Mayo Clinic Proceedings: Digital Health. 2024; 2 (3):470-6
  8. Hu C, Iyer RK, Juran BD, McCauley BM, Atkinson EJ, Eaton JE, Ali AH, Lazaridis KN. Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data. BMC Gastroenterol. 2023 Apr 19; 23 (1):129
    View PubMed
  9. Corpechot C, Carrat F, Gaouar F, Chau F, Hirschfield G, Gulamhusein A, Montano-Loza AJ, Lytvyak E, Schramm C, Pares A, Olivas I, Eaton JE, Osman KT, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Dumortier J, Bruns T, Grosse K, Pageaux GP, Wetten A, Dyson J, Jones D, Chazouilleres O, Hansen B, de Ledinghen V, Global & ERN Rare-Liver PBC Study Groups. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis. J Hepatol. 2022 Dec; 77 (6):1545-1553 Epub 2022 June 28
    View PubMed
  10. Visseren T, Erler NS, Heimbach JK, Eaton JE, Selzner N, Gulamhusein A, van der Heide F, Porte RJ, van Hoek B, Alwayn IPJ, Metselaar HJ, IJzermans JNM, Darwish Murad S. Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study. JHEP Rep. 2022 Dec; 4 (12):100599 Epub 2022 Oct 01
    View PubMed
  11. Singh Y, Jons WA, Eaton JE, Vesterhus M, Karlsen T, Bjoerk I, Abildgaard A, Jorgensen KK, Folseraas T, Little D, Gulamhusein AF, Petrovic K, Negard A, Conte GM, Sobek JD, Jagtap J, Venkatesh SK, Gores GJ, LaRusso NF, Lazaridis KN, Erickson BJ. Algebraic topology-based machine learning using MRI predicts outcomes in primary sclerosing cholangitis. Eur Radiol Exp. 2022 Nov 18; 6 (1):58
    View PubMed
  12. Carey EJ, Eaton J, Clayton M, Gossard A, Iqbal S, Ullah H, Zhang N, Butterfield R, Lindor KD. A pilot study of vidofludimus calcium for treatment of primary sclerosing cholangitis. Hepatol Commun. 2022 Jul; 6 (7):1589-1597 Epub 2022 Mar 03
    View PubMed
  13. Miyabe K, Chandrasekhara V, Wongjarupong N, Chen J, Yang L, Johnson S, Chia N, Walther-Antonio M, Yao JZ, Harrington SC, Nordyke CK, Eaton JE, Gossard AA, Oli S, Ali HA, Lavu S, Giama NH, Hassan FA, Ali HM, Enders FT, Ilyas SI, Gores GJ, Topazian MD, Kashyap PC, Roberts LR. Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma. Cancers (Basel). 2022 Apr 24; 14 (9)
    View PubMed
  14. Eaton JE, Haseeb A, Rupp C, Eusebi LH, van Munster K, Voitl R, Thorburn D, Ponsioen CY, Enders FT, Petersen BT, Abu Dayyeh BK, Baron TH, Chandrasekhara V, Gostout CJ, Levy MJ, Martin J, Storm AC, Dierkhising R, Kamath PS, Gores GJ, Topazian M. Predictors of Jaundice Resolution and Survival After Endoscopic Treatment of Primary Sclerosing Cholangitis. Hepatol Commun. 2022 Apr; 6 (4):809-820 Epub 2021 Sept 01
    View PubMed
  15. Venkatesh SK, L Welle C, H Miller F, Jhaveri K, Ringe KI, Eaton JE, Bungay H, Arrive L, Ba-Ssalamah A, Grigoriadis A, Schramm C, Fulcher AS, IPSCSG. Correction to: Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Eur Radiol. 2022 Apr; 32 (4):2860
    View PubMed
  16. Zhao-Fleming HH, Davidson TM, Eaton JE. 55-Year-Old Woman With Abnormal Liver Test Results. Mayo Clin Proc. 2022 Mar; 97 (3):614-619 Epub 2022 Feb 05
    View PubMed
  17. Venkatesh SK, Welle CL, Miller FH, Jhaveri K, Ringe KI, Eaton JE, Bungay H, Arrive L, Ba-Ssalamah A, Grigoriadis A, Schramm C, Fulcher AS, IPSCSG. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Eur Radiol. 2022 Feb; 32 (2):923-937 Epub 2021 Aug 06
    View PubMed
  18. Eaton JE, Welle CL, Monahan H, Tahboub Amawi AD, Idilman I, Harmsen WS, Dzyubak B, Beiermann EW, Bakhshi Z, Gores GJ, LaRusso NF, Gossard AA, Lazaridis KN, Venkatesh SK. Comparative Performance of Quantitative and Qualitative Magnetic Resonance Imaging Metrics in Primary Sclerosing Cholangitis. Gastro Hep Adv. 2022; 1 (3):287-295 Epub 2022 Mar 30
    View PubMed
  19. Mousa OY, Juran BD, McCauley BM, Vesterhus MN, Folseraas T, Turgeon CT, Ali AH, Schlicht EM, Atkinson EJ, Hu C, Harnois D, Carey EJ, Gossard AA, Oglesbee D, Eaton JE, LaRusso NF, Gores GJ, Karlsen TH, Lazaridis KN. Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation. Hepatology. 2021 Jul; 74 (1):281-295 Epub 2021 June 15
    View PubMed
  20. Eaton JE, Welle CL, Bakhshi Z, Sheedy SP, Idilman IS, Gores GJ, Rosen CB, Heimbach JK, Taner T, Harnois DM, Lindor KD, LaRusso NF, Gossard AA, Lazaridis KN, Venkatesh SK. Early Cholangiocarcinoma Detection With Magnetic Resonance Imaging Versus Ultrasound in Primary Sclerosing Cholangitis. Hepatology. 2021 May; 73 (5):1868-1881 Epub 2021 Apr 19
    View PubMed
  21. Hilscher MB, Kamath PS, Eaton JE. Cholestatic Liver Diseases: A Primer for Generalists and Subspecialists. Mayo Clin Proc. 2020 Oct; 95 (10):2263-2279
    View PubMed
  22. Osman KT, Maselli DB, Idilman IS, Rowan DJ, Viehman JK, Harmsen WS, Harnois DM, Carey EJ, Gossard AA, LaRusso NF, Lindor KD, Venkatesh SK, Eaton JE. Liver Stiffness Measured by Either Magnetic Resonance or Transient Elastography Is Associated With Liver Fibrosis and Is an Independent Predictor of Outcomes Among Patients With Primary Biliary Cholangitis. J Clin Gastroenterol. 2020 Sep 23 Epub 2020 Sept 23
    View PubMed
  23. Idilman IS, Venkatesh SH, Eaton JE, Bolan CW, Osman KT, Maselli DB, Menias CO, Venkatesh SK. Magnetic resonance imaging features in 283 patients with primary biliary cholangitis. Eur Radiol. 2020 Sep; 30 (9):5139-5148 Epub 2020 Apr 26
    View PubMed
  24. Kozaka K, Sheedy SP, Eaton JE, Venkatesh SK, Heiken JP. Magnetic resonance imaging features of small-duct primary sclerosing cholangitis. Abdom Radiol (NY). 2020 Aug; 45 (8):2388-2399
    View PubMed
  25. Eaton JE, Sen A, Hoodeshenas S, Schleck CD, Harmsen WS, Gores GJ, LaRusso NF, Gossard AA, Lazaridis KN, Venkatesh SK. Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol. 2020 Jun; 18 (7):1576-1583.e1 Epub 2019 Nov 01
    View PubMed
  26. Bakhshi Z, Hilscher MB, Gores GJ, Harmsen WS, Viehman JK, LaRusso NF, Gossard AA, Lazaridis KN, Lindor KD, Eaton JE. An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort. J Gastroenterol. 2020 May; 55 (5):523-532 Epub 2020 Jan 13
    View PubMed
  27. Eaton JE, Vuppalanchi R, Reddy R, Sathapathy S, Ali B, Kamath PS. Liver Injury in Patients With Cholestatic Liver Disease Treated With Obeticholic Acid. Hepatology. 2020 Apr; 71 (4):1511-1514 Epub 2020 Mar 24
    View PubMed
  28. Idilman IS, Low HM, Bakhshi Z, Eaton J, Venkatesh SK. Comparison of liver stiffness measurement with MRE and liver and spleen volumetry for prediction of disease severity and hepatic decompensation in patients with primary sclerosing cholangitis. Abdom Radiol (NY). 2020 Mar; 45 (3):701-709
    View PubMed
  29. Eaton JE, Vesterhus M, McCauley BM, Atkinson EJ, Schlicht EM, Juran BD, Gossard AA, LaRusso NF, Gores GJ, Karlsen TH, Lazaridis KN. Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning. Hepatology. 2020 Jan; 71 (1):214-224 Epub 2018 Dec 28
    View PubMed
  30. Vaxman I, Eaton J, Lee HE, Gertz MA. Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide. Case Rep Transplant. 2020; 2020:8894922. Epub 2020 Dec 12.
    View PubMed
  31. Hoodeshenas S, Welle CL, Navin PJ, Dzyubak B, Eaton JE, Ehman RL, Venkatesh SK. Magnetic Resonance Elastography in Primary Sclerosing Cholangitis: Interobserver Agreement for Liver Stiffness Measurement with Manual and Automated Methods. Acad Radiol. 2019 Dec; 26 (12):1625-1632 Epub 2019 Mar 14
    View PubMed
  32. Wang XJ, Eaton JE. Whipworm Found During a Colonoscopy. ACG Case Rep J. 2019 Oct; 6 (10):e00259 Epub 2019 Oct 22
    View PubMed
  33. Zenouzi R, Welle CL, Venkatesh SK, Schramm C, Eaton JE. Magnetic Resonance Imaging in Primary Sclerosing Cholangitis-Current State and Future Directions. Semin Liver Dis. 2019 Jul; 39 (3):369-380 Epub 2019 Apr 30
    View PubMed
  34. Eaton JE, Gores GJ. Long-term outcomes with obeticholic acid in primary biliary cholangitis: reassuring, but still an itch we need to scratch. Lancet Gastroenterol Hepatol 2019 Jun; 4 (6):417-418 Epub 2019 Mar 26
    View PubMed
  35. Eaton JE, Nelson KM, Gossard AA, Carey EJ, Tabibian JH, Lindor KD, LaRusso NF. Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study. Scand J Gastroenterol. 2019 May; 54 (5):633-639 Epub 2019 May 26
    View PubMed
  36. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019 Jan; 70 (1):151-171 Epub 2018 Sept 26
    View PubMed
  37. Bookwalter CA, Venkatesh SK, Eaton JE, Smyrk TD, Ehman RL. MR elastography in primary sclerosing cholangitis: correlating liver stiffness with bile duct strictures and parenchymal changes. Abdom Radiol (NY). 2018 Dec; 43 (12):3260-3270
    View PubMed
  38. Alberts R, de Vries EMG, Goode EC, Jiang X, Sampaziotis F, Rombouts K, Bottcher K, Folseraas T, Weismuller TJ, Mason AL, Wang W, Alexander G, Alvaro D, Bergquist A, Bjorkstrom NK, Beuers U, Bjornsson E, Boberg KM, Bowlus CL, Bragazzi MC, Carbone M, Chazouilleres O, Cheung A, Dalekos G, Eaton J, Eksteen B, Ellinghaus D, Farkkila M, Festen EAM, Floreani A, Franceschet I, Gotthardt DN, Hirschfield GM, Hoek BV, Holm K, Hohenester S, Hov JR, Imhann F, Invernizzi P, Juran BD, Lenzen H, Lieb W, Liu JZ, Marschall HU, Marzioni M, Melum E, Milkiewicz P, Muller T, Pares A, Rupp C, Rust C, Sandford RN, Schramm C, Schreiber S, Schrumpf E, Silverberg MS, Srivastava B, Sterneck M, Teufel A, Vallier L, Verheij J, Vila AV, Vries B, Zachou K, Chapman RW, Manns MP, Pinzani M, Rushbrook SM, Lazaridis KN, Franke A, Anderson CA, Karlsen TH, Ponsioen CY, Weersma RK, International PSC Study Group, The UK PSC Consortium. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis. Gut. 2018 Aug; 67 (8):1517-1524 Epub 2017 Aug 04
    View PubMed
  39. Venkatesh SK, Eaton JE, Liwinski T, Yamamura J, Weiler-Normann C, Sebode M, Keller S, Lohse AW, Schramm C, International PSC Study Group (IPSCSG). Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret. Aliment Pharmacol Ther. 2018 Jul; 48 (2):169-178 Epub 2018 May 09
    View PubMed
  40. Ilyas SI, Eaton J, Yang JD, Chandrasekhara V, Gores GJ. Emerging Technologies for the Diagnosis of Perihilar Cholangiocarcinoma. Semin Liver Dis. 2018 May; 38 (2):160-169 Epub 2018 June 05
    View PubMed
  41. Schramm C, Eaton J, Ringe KI, Venkatesh S, Yamamura J, MRI working group of the IPSCSG. Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group. Hepatology. 2017 Nov; 66 (5):1675-1688 Epub 2017 Sept 29
    View PubMed
  42. Eaton JE, McCauley BM, Atkinson EJ, Juran BD, Schlicht EM, de Andrade M, Lazaridis KN. Variations in primary sclerosing cholangitis across the age spectrum. J Gastroenterol Hepatol. 2017 Oct; 32 (10):1763-1768
    View PubMed
  43. Assis DN, Abdelghany O, Cai SY, Gossard AA, Eaton JE, Keach JC, Deng Y, Setchell KD, Ciarleglio M, Lindor KD, Boyer JL. Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study. J Clin Gastroenterol. 2017 Feb; 51 (2):e11-e16
    View PubMed
  44. Ji SG, Juran BD, Mucha S, Folseraas T, Jostins L, Melum E, Kumasaka N, Atkinson EJ, Schlicht EM, Liu JZ, Shah T, Gutierrez-Achury J, Boberg KM, Bergquist A, Vermeire S, Eksteen B, Durie PR, Farkkila M, Muller T, Schramm C, Sterneck M, Weismuller TJ, Gotthardt DN, Ellinghaus D, Braun F, Teufel A, Laudes M, Lieb W, Jacobs G, Beuers U, Weersma RK, Wijmenga C, Marschall HU, Milkiewicz P, Pares A, Kontula K, Chazouilleres O, Invernizzi P, Goode E, Spiess K, Moore C, Sambrook J, Ouwehand WH, Roberts DJ, Danesh J, Floreani A, Gulamhusein AF, Eaton JE, Schreiber S, Coltescu C, Bowlus CL, Luketic VA, Odin JA, Chopra KB, Kowdley KV, Chalasani N, Manns MP, Srivastava B, Mells G, Sandford RN, Alexander G, Gaffney DJ, Chapman RW, Hirschfield GM, de Andrade M, Rushbrook SM, Franke A, Karlsen TH, Lazaridis KN, Anderson CA, UK-PSC Consortium//International IBD Genetics Consortium//International PSC Study Group. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genet. 2017 Feb; 49 (2):269-273 Epub 2016 Dec 19
    View PubMed
  45. Tabibian JH, Gossard A, El-Youssef M, Eaton JE, Petz J, Jorgensen R, Enders FB, Tabibian A, Lindor KD. Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis. Am J Ther. 2017 Jan/Feb; 24 (1):e56-e63
    View PubMed
  46. Noelting J, Eaton JE, Choung RS, Zinsmeister AR, Locke GR 3rd, Bharucha AE. The incidence rate and characteristics of clinically diagnosed defecatory disorders in the community. Neurogastroenterol Motil. 2016 Nov; 28 (11):1690-1697 Epub 2016 June 02
    View PubMed
  47. Eaton JE, Dzyubak B, Venkatesh SK, Smyrk TC, Gores GJ, Ehman RL, LaRusso NF, Gossard AA, Lazaridis KN. Performance of magnetic resonance elastography in primary sclerosing cholangitis. J Gastroenterol Hepatol. 2016 Jun; 31 (6):1184-90
    View PubMed
  48. Gulamhusein AF, Eaton JE, Tabibian JH, Atkinson EJ, Juran BD, Lazaridis KN. Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD. Am J Gastroenterol. 2016 May; 111 (5):705-11 Epub 2016 Mar 22
    View PubMed
  49. Ilyas SI, Eaton JE, Gores GJ. Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management. Clin Gastroenterol Hepatol. 2015 Nov; 13 (12):2152-65 Epub 2015 June 05
    View PubMed
  50. Eaton JE, Juran BD, Atkinson EJ, Schlicht EM, Xie X, de Andrade M, Lammert CS, Luketic VA, Odin JA, Koteish AA, Kowdley KV, Chopra KB, Hirschfield GM, Chalasani NP, Lazaridis KN. A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Aliment Pharmacol Ther. 2015 May; 41 (10):980-90 Epub 2015 Mar 17
    View PubMed
  51. Eaton JE, Barr Fritcher EG, Gores GJ, Atkinson EJ, Tabibian JH, Topazian MD, Gossard AA, Halling KC, Kipp BR, Lazaridis KN. Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol. 2015 Feb; 110 (2):299-309 Epub 2015 Jan 27
    View PubMed
  52. Imam MH, Eaton JE, Puckett JS, Loftus EV Jr, Mathis KL, Gossard AA, Talwalkar JA, Lindor KD. Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis. J Crohns Colitis. 2014 Oct; 8: (10)1294-9.
    View PubMed
  53. Singh S, Eaton JE, Murad MH, Tanaka H, Iijima H, Talwalkar JA. Accuracy of spleen stiffness measurement in detection of esophageal varices in patients with chronic liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014 Jun; 12 (6):935-45.e4 Epub 2013 Sept 18
    View PubMed
  54. Eaton JE, Gossard AA, Talwalkar JA. Recall processes for biliary cytology in primary sclerosing cholangitis. Curr Opin Gastroenterol. 2014 May; 30(3):287-94.
    View PubMed
  55. Eaton JE, Smyrk TC, Imam M, Pardi DS, Loftus EV Jr, Owens VL, Talwalkar JA. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation. Aliment Pharmacol Ther. 2013 Oct; 38 (8):977-87 Epub 2013 Aug 29
    View PubMed
  56. Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology. 2013 Sep; 145 (3):521-36 Epub 2013 July 01
    View PubMed
  57. Eaton JE, Reed DA, Aboff BM, Call SA, Chelminski PR, Thanarajasingam U, Post JA, Thomas KG, Dupras DM, Beckman TJ, West CP, Wittich CM, Halvorsen AJ, McDonald FS. Update in internal medicine residency education: a review of the literature in 2010 and 2011. J Grad Med Educ. 2013 Jun; 5 (2):203-10
    View PubMed
  58. Eaton JE, Talwalkar JA. Primary Sclerosing Cholangitis: Current and Future Management Strategies. Curr Hepat Rep. 2013 Mar 1; 12 (1):28-36
    View PubMed
  59. Eaton J, Reed D, Angstman KB, Thomas K, North F, Stroebel R, Tulledge-Scheitel SM, Chaudhry R. Effect of visit length and a clinical decision support tool on abdominal aortic aneurysm screening rates in a primary care practice. J Eval Clin Pract. 2012 Jun; 18 (3):593-8 Epub 2011 Jan 06
    View PubMed
  60. Eaton JE, Thackeray EW, Lindor KD. Likelihood of malignancy in gallbladder polyps and outcomes following cholecystectomy in primary sclerosing cholangitis. Am J Gastroenterol. 2012 Mar; 107(3):431-9. Epub 2011 Oct 25.
    View PubMed
  61. Eaton JE, Silveira MG, Pardi DS, Sinakos E, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Lindor KD. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol. 2011 Sep; 106 (9):1638-45 Epub 2011 May 10
    View PubMed
PST-20299055